Stocks and InvestingStocks and Investing
Fri, August 10, 2018
Thu, August 9, 2018
Wed, August 8, 2018
Tue, August 7, 2018
Mon, August 6, 2018
Fri, August 3, 2018

David Lebovitz Maintained (ALNY) at Hold with Decreased Target to $99 on, Aug 3rd, 2018


Published on 2024-10-26 07:37:46 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $107 to $99 on, Aug 3rd, 2018.

David has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Stephen Willey of "Stifel" Maintained at Hold with Decreased Target to $95 on, Friday, May 4th, 2018


This is the rating of the analyst that currently disagrees with David


  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $134 on, Friday, May 4th, 2018